Vaccitech’s $110.5 Million Initial Public Offering

Goodwin Procter LLP advised Vaccitech on the deal, while Davis Polk advised the representatives of the several underwriters.Vaccitech (Nasdaq: VACC) announced its initial public offering in…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here